Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ATP13A2 Antikörper (C-Term)

ATP13A2 Reaktivität: Human WB, EIA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN950560
  • Target Alle ATP13A2 Antikörper anzeigen
    ATP13A2 (ATPase Type 13A2 (ATP13A2))
    Bindungsspezifität
    • 15
    • 7
    • 6
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1132-1161, C-Term
    Reaktivität
    • 24
    • 18
    • 4
    • 1
    Human
    Wirt
    • 37
    • 3
    Kaninchen
    Klonalität
    • 38
    • 2
    Polyklonal
    Konjugat
    • 15
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ATP13A2 Antikörper ist unkonjugiert
    Applikation
    • 19
    • 19
    • 13
    • 13
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Spezifität
    This antibody reacts to ATP13A2.
    Kreuzreaktivität (Details)
    Species reactivity (tested):Human.
    Aufreinigung
    Affinity chromatography on Protein A
    Immunogen
    KLH conjugated synthetic peptide between 1132-1161 amino acids from the C-terminal region of human ATP13A2
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product ATP13A2 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.25 mg/mL
    Buffer
    PBS containing 0.09 % (W/V) sodium azide as preservative
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target
    ATP13A2 (ATPase Type 13A2 (ATP13A2))
    Andere Bezeichnung
    ATP13A2 / PARK9 (ATP13A2 Produkte)
    Synonyme
    ATP13A2 antikoerper, 1110012E06Rik antikoerper, AA589443 antikoerper, RGD1307977 antikoerper, im:7147302 antikoerper, zgc:136762 antikoerper, CLN12 antikoerper, HSA9947 antikoerper, KRPPD antikoerper, PARK9 antikoerper, ATPase 13A2 antikoerper, ATPase type 13A2 antikoerper, probable cation-transporting ATPase 13A2 antikoerper, ATP13A2 antikoerper, Atp13a2 antikoerper, atp13a2 antikoerper, PTRG_01071 antikoerper, MCYG_01937 antikoerper, LOC100439053 antikoerper
    Hintergrund
    This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.Synonyms: Probable cation-transporting ATPase 13A2
    Gen-ID
    23400
    NCBI Accession
    NP_001135446
    Pathways
    Ribonucleoside Biosynthetic Process
Sie sind hier:
Kundenservice